Intelligent Bio Solutions Inc. (INBS)
Nasdaq: INBS · Surgical & Medical Instruments & Apparatus · New York, NY · filing with the SEC since 2017
Who owns Intelligent Bio Solutions Inc.
As filed with the SECHolders of 5% or more
2
Alyeska Investment Group, L.P. holds 9.99% of Class A Common Stock, $0.001 par value, as its SCHEDULE 13G/A filed Nov 14, 2025 says.
Directors and officers
6
report now, of 14 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Alyeska Investment Group, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Class A Common Stock, $0.001 par value
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · 9.99% in May 15, 2026
Bigger Michael
SCHEDULE 13G/A · filed Feb 4, 2025 · Common Stock, $0.01 par value · reported falling below 5%
What INBS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Ladenburg Thalmann & Co. Inc
An entity · legal entity · owns, named in the 10-K filed Aug 19, 2026
3 subsidiaries in 3 countries, from the list filed with the 10-K filed Aug 19, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.